AIMS: Most programs specializing in the treatment of first-episode psychosis in the United States focus on schizophrenia. However, many early psychosis patients do not fit into this diagnostic category. Here we describe McLean OnTrack, an intensive outpatient treatment program that accepts all comers with first-episode psychosis. METHODS: We assessed baseline characteristics of patients in the 2.5 years since program initiation. We examined how initial referral diagnoses compare with current diagnoses, calculating the proportion of diagnostic changes. RESULTS: At 2.5 years, patients in McLean OnTrack consist of 30 (33.0%) individuals with primary psychotic disorder, 40 (44.0%) with affective psychosis, 19 (20.9%) with psychotic disorder not otherwise specified (NOS) who do not meet full criteria for either category and two (2.2%) individuals with no psychosis. Although patients with affective psychosis had higher pre-morbid functioning, all three categories of psychosis had similar rates of prior hospitalizations and substance use. The retention rate in the psychotic disorder NOS group was lower than that in affective and primary psychotic disorders. Finally, diagnoses changed over the course of treatment in 50.5% of patients. CONCLUSIONS: Diagnostic heterogeneity appears to be the norm among patients with first-episode psychosis, and diagnoses commonly evolve over the illness course. Baseline indices of illness severity were similar across categories and suggest the need for early intervention, irrespective of specific diagnosis. We discuss the benefits and challenges of a transdiagnostic approach to early intervention in first-episode psychosis, treating patients who share many but not all characteristics.
AIMS: Most programs specializing in the treatment of first-episode psychosis in the United States focus on schizophrenia. However, many early psychosispatients do not fit into this diagnostic category. Here we describe McLean OnTrack, an intensive outpatient treatment program that accepts all comers with first-episode psychosis. METHODS: We assessed baseline characteristics of patients in the 2.5 years since program initiation. We examined how initial referral diagnoses compare with current diagnoses, calculating the proportion of diagnostic changes. RESULTS: At 2.5 years, patients in McLean OnTrack consist of 30 (33.0%) individuals with primary psychotic disorder, 40 (44.0%) with affective psychosis, 19 (20.9%) with psychotic disorder not otherwise specified (NOS) who do not meet full criteria for either category and two (2.2%) individuals with no psychosis. Although patients with affective psychosis had higher pre-morbid functioning, all three categories of psychosis had similar rates of prior hospitalizations and substance use. The retention rate in the psychotic disorder NOS group was lower than that in affective and primary psychotic disorders. Finally, diagnoses changed over the course of treatment in 50.5% of patients. CONCLUSIONS: Diagnostic heterogeneity appears to be the norm among patients with first-episode psychosis, and diagnoses commonly evolve over the illness course. Baseline indices of illness severity were similar across categories and suggest the need for early intervention, irrespective of specific diagnosis. We discuss the benefits and challenges of a transdiagnostic approach to early intervention in first-episode psychosis, treating patients who share many but not all characteristics.
Authors: Patrick D McGorry; Rosemary Purcell; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson Journal: Med J Aust Date: 2007-10-01 Impact factor: 7.738
Authors: F Kapczinski; P V S Magalhães; V Balanzá-Martinez; V V Dias; S Frangou; C S Gama; A Gonzalez-Pinto; I Grande; K Ha; M Kauer-Sant'Anna; M Kunz; R Kupka; M Leboyer; C Lopez-Jaramillo; R M Post; J K Rybakowski; J Scott; S Strejilevitch; M Tohen; G Vazquez; L Yatham; E Vieta; M Berk Journal: Acta Psychiatr Scand Date: 2014-06-25 Impact factor: 6.392
Authors: César González-Blanch; John F Gleeson; Peter Koval; Sue M Cotton; Patrick D McGorry; Mario Alvarez-Jimenez Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240
Authors: Anna-Leigh Powell; Cassandra Hinger; Erica D Marshall-Lee; Tonya Miller-Roberts; Kayla Phillips Journal: Community Ment Health J Date: 2020-05-29
Authors: Virginie-Anne Chouinard; Sang-Young Kim; Linda Valeri; Cagri Yuksel; Kyle P Ryan; Guy Chouinard; Bruce M Cohen; Fei Du; Dost Öngür Journal: Schizophr Res Date: 2017-03-01 Impact factor: 4.939
Authors: Shi Yu Chan; Roscoe O Brady; Kathryn E Lewandowski; Amy Higgins; Dost Öngür; Mei-Hua Hall Journal: Mol Psychiatry Date: 2021-10-25 Impact factor: 13.437
Authors: Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire Journal: World Psychiatry Date: 2019-06 Impact factor: 49.548
Authors: Philip B Cawkwell; Kirsten W Bolton; Rakesh Karmacharya; Dost Öngür; Ann K Shinn Journal: Early Interv Psychiatry Date: 2020-02-10 Impact factor: 2.732